You are here

oncology

BMS returns $475M IL-12 oncology asset to Dragonfly’s pond

Fierce Biotech

Mon, 02/6/23 - 06:12 pm

Dragonfly Therapeutics

Bristol Myers Squibb

Oncology, HIV sales lift Gilead’s revenues by 2%

Medical Marketing and Media

Thu, 02/2/23 - 11:09 pm

Gilead Sciences

Immuno-oncology goes subcutaneous

EP Vantage

Wed, 01/25/23 - 10:18 am

immuno-oncology

subcutaneous drug delivery

Bayer’s oncology business looks to collect $10B in sales by 2030, exec says

Fierce Pharma

Tue, 01/24/23 - 10:38 am

prostatce caner

Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is

Stat

Sun, 01/22/23 - 01:05 pm

FDA details approach for finding optimal dosages for new cancer drugs

RAPS.org

Wed, 01/18/23 - 10:42 am

Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop

Fierce Pharma

Mon, 01/16/23 - 11:16 am

BMJ finds 96% of oncology drug developers inadequately include minority groups

Clinical Trials Arena

Fri, 01/13/23 - 11:06 am

drug development

Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug

Stat

Wed, 01/11/23 - 10:51 am

prostate cancer

AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets

Fierce Biotech

Tue, 01/10/23 - 11:05 am

small molecule drugs

undruggable targets

UK signs deal with BioNTech for cutting-edge cancer trials

Financial Times

Fri, 01/6/23 - 09:35 am

clinical trials

Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says

Fierce Biotech

Thu, 01/5/23 - 10:09 am

clinical trials

clinical trial diversity

United Therapeutics

Bristol Myers Squibb

Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal

BioSpace

Thu, 12/22/22 - 10:44 am

antibody-drug conjugate

Biosimilars hit a turning point as they expand outside oncology

Clinical Trials Arena

Fri, 12/9/22 - 10:31 am

gastroenterology

metabolic disorders

musculoskeletal disorders

Cancer drugmaker Plexxikon gets new life as Opna Bio

BioPharma Dive

Tue, 11/22/22 - 10:38 am

Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds

MedCity News

Sun, 11/20/22 - 12:37 pm

Acrivon Therapeutics

FDA wants confirmatory trials to be underway before granting accelerated cancer nods, Pazdur says

RAPS.org

Fri, 11/18/22 - 10:32 am

accelerated approvals

Baltimore Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round

Bizjournals

Wed, 11/16/22 - 10:29 am

Haystack Oncology

Pharma marketers: Keep oncology HCP messaging short with a compelling brand story, says report

Fierce Pharma

Wed, 11/9/22 - 01:56 pm

pharma marketing

Alkermes to hive off oncology business

Pharma Letter

Thu, 11/3/22 - 10:55 am

Pages